Bevacizumab (Avastin)
Drug timelines are a Plus or Pro feature.
81 regulatory and trial events tracked for Bevacizumab (Avastin), covering 2007-02-22 to 2026-06-17. Get the full timeline:
Most recent: Clinical Trial Results: To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects [Phase 1]